Provides relative to certain prescriptive periods for delictual actions. (8/1/24)
Impact
The proposed modifications would significantly change the landscape of personal injury litigation in Louisiana. Increasing the prescriptive period gives potential plaintiffs more time to act but also introduces conditions that require them to notify insurers and potential defendants of their medical treatments within ninety days. Failure to comply would bar recovery for those treatments, emphasizing the need for timely disclosure in the pursuit of legal actions.
Summary
Senate Bill 334, proposed by Senator Talbot, aims to amend Louisiana's Civil Code by increasing the prescriptive periods for certain delictual actions, specifically personal injury cases, from one year to two years. This change intends to provide plaintiffs more time to pursue legal actions after sustaining injuries, which advocates argue is necessary to ensure justice for those who may not realize they have a valid claim until after the initial one-year limitation has passed. Additionally, the bill introduces new stipulations regarding the disclosure of medical treatment pertinent to personal injury actions.
Sentiment
The sentiment surrounding SB 334 is mixed. Proponents argue that extending the prescriptive period could help more individuals seek recovery for their injuries, thus diminishing instances where victims miss their chances due to overly restrictive statutes of limitations. Conversely, critics raise concerns that the bill’s disclosure requirements may create additional obstacles for claimants, particularly those who are already dealing with the repercussions of their injuries. Overall, the discourse reflects a balance between protecting patients’ rights and ensuring fair practices in legal processes.
Contention
Notable points of contention surrounding SB 334 include its potential implications on various aspects of personal injury litigation, such as the rights of plaintiffs to recover treatment costs and the obligations placed upon them to provide timely notifications. The bill may be perceived as a double-edged sword; while it potentially offers greater access to justice, it may also impose rigorous administrative burdens on injured parties, thus complicating their path to recovery.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.